Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 2867422)

Published in Am J Physiol Gastrointest Liver Physiol on March 04, 2010

Authors

Yong Zhou1, Elizabeth J Dial, Rand Doyen, Lenard M Lichtenberger

Author Affiliations

1: Department of Pediatrics-Gastroenterology, Baylor College of Medicine, Houston, TX, USA.

Articles citing this

Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol (2013) 1.10

NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol (2012) 1.03

Non-steroidal anti-inflammatory drug-induced enteropathy. Clin Endosc (2012) 0.93

Bile acids modulate signaling by functional perturbation of plasma membrane domains. J Biol Chem (2013) 0.88

Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges. Gastroenterol Res Pract (2013) 0.81

In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion (2012) 0.80

Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety. Gut Liver (2012) 0.80

Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation. Int J Mol Sci (2010) 0.78

Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. Br J Pharmacol (2013) 0.77

Indomethacin-induced translocation of bacteria across enteric epithelia is reactive oxygen species-dependent and reduced by vitamin C. Am J Physiol Gastrointest Liver Physiol (2012) 0.76

Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability. PLoS One (2016) 0.76

Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions. Pharmaceuticals (Basel) (2010) 0.76

In vitro evidence that phosphatidylcholine protects against indomethacin/bile acid-induced injury to cells. Am J Physiol Gastrointest Liver Physiol (2014) 0.76

Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci. Physiol Rep (2016) 0.75

Gata4 is critical to maintain gut barrier function and mucosal integrity following epithelial injury. Sci Rep (2016) 0.75

Articles cited by this

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol (1971) 37.53

The electrostatic properties of membranes. Annu Rev Biophys Biophys Chem (1989) 5.37

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology (1993) 4.93

Liposome-cell interaction: transfer and intracellular release of a trapped fluorescent marker. Science (1977) 2.89

Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci (2008) 2.60

Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol (2005) 2.54

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol (2005) 2.50

Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion (2009) 2.43

Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med (1995) 2.15

Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology (1981) 2.13

Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation (1993) 2.03

The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol (1995) 1.85

Quasielastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions. Biochemistry (1980) 1.80

Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods (2000) 1.68

The influence of bile salt structure on self-association in aqueous solutions. J Biol Chem (1983) 1.62

Micellar properties of dihydroxy and trihydroxy bile salts: effects of counterion and temperature. J Colloid Interface Sci (1969) 1.60

The biophysics of lipidic associations. I. The ternary systems: lecithin-bile salt-water. Biochim Biophys Acta (1966) 1.60

The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. Gastroenterology (2004) 1.58

The dipole potential of phospholipid membranes and methods for its detection. Adv Colloid Interface Sci (2001) 1.48

Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol (1975) 1.46

Influence of anions and cations on the dipole potential of phosphatidylcholine vesicles: a basis for the Hofmeister effect. Biophys J (1999) 1.44

Optical detection of membrane dipole potential: avoidance of fluidity and dye-induced effects. Biochim Biophys Acta (1997) 1.23

Effect of lipid structure on the dipole potential of phosphatidylcholine bilayers. Biochim Biophys Acta (1997) 1.21

Lateral organization and domain formation in a two-component lipid membrane system. Biophys J (2001) 1.15

Imaging of small bowel disease: comparison of capsule endoscopy, standard endoscopy, barium examination, and CT. Radiographics (2005) 1.13

Quasielastic light scattering studies of aqueous biliary lipid systems. Size, shape, and thermodynamics of bile salt micelles. Biochemistry (1979) 1.12

Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol (2007) 1.06

Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem Pharmacol (1999) 1.04

NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes. J Pharm Pharmacol (2006) 1.03

Cholesterol effect on the dipole potential of lipid membranes. Biophys J (2006) 1.00

Solution pH alters mechanical and electrical properties of phosphatidylcholine membranes: relation between interfacial electrostatics, intramembrane potential, and bending elasticity. Biophys J (2006) 0.99

Does aspirin damage canine gastric mucosa by reducing its surface hydrophobicity? Am J Physiol (1987) 0.97

Electric field strength of membrane lipids from vertebrate species: membrane lipid composition and Na+-K+-ATPase molecular activity. Am J Physiol Regul Integr Comp Physiol (2004) 0.97

Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface. Analysis with a phospholipid-selective cytochemical stain. Gastroenterology (1990) 0.97

Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injury. J Gastroenterol Hepatol (2007) 0.94

Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts. Clin Biochem (2007) 0.94

Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes. J Gastroenterol Hepatol (2007) 0.93

The mode of action of aspirin-like drugs. Agents Actions (1978) 0.93

The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acid. Biochim Biophys Acta (2008) 0.89

Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates. Biochemistry (1981) 0.88

Bile acid/phosphatidylcholine interactions in mixed monomolecular layers: differences in condensation effects but not interfacial orientation between hydrophobic and hydrophilic bile acid species. Biochemistry (1995) 0.87

Lecithin translational diffusion studied by pulsed nuclear magnetic resonance. Biophys J (1976) 0.87

In vitro recovery of canine gastric mucosal surface hydrophobicity and potential difference after aspirin damage. Dig Dis Sci (1995) 0.86

Diaphragmlike strictures of the small bowel associated with use of nonsteroidal antiinflammatory drugs. AJR Am J Roentgenol (1994) 0.85

The nonsteroidal anti-inflammatory drug indomethacin induces heterogeneity in lipid membranes: potential implication for its diverse biological action. PLoS One (2010) 0.85

Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury. Dig Dis Sci (2006) 0.83

Indomethacin disrupts the protective effect of phosphatidylcholine against bile salt-induced ileal mucosa injury. Eur J Clin Invest (2006) 0.83

Clearance of indomethacin occurs predominantly by renal glucuronidation. Pharm Weekbl Sci (1992) 0.77

Articles by these authors

The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. Gastroenterology (2004) 1.58

NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes. J Pharm Pharmacol (2006) 1.03

Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine. Biochim Biophys Acta (2012) 0.97

Bile acids improve the antimicrobial effect of rifaximin. Antimicrob Agents Chemother (2010) 0.97

Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injury. J Gastroenterol Hepatol (2007) 0.94

Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes. J Gastroenterol Hepatol (2007) 0.93

Pathophysiology of LPS-induced gastrointestinal injury in the rat: role of secretory phospholipase A2. Shock (2008) 0.92

The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acid. Biochim Biophys Acta (2008) 0.89

Lipopolysaccharide-induced gastrointestinal injury in rats: role of surface hydrophobicity and bile salts. Shock (2002) 0.89

Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro. Cancer Chemother Pharmacol (2005) 0.88

Bile acids modulate signaling by functional perturbation of plasma membrane domains. J Biol Chem (2013) 0.88

The anti-inflammatory drug indomethacin alters nanoclustering in synthetic and cell plasma membranes. J Biol Chem (2010) 0.88

Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial. Am J Gastroenterol (2010) 0.88

A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury. Shock (2010) 0.87

The nonsteroidal anti-inflammatory drug indomethacin induces heterogeneity in lipid membranes: potential implication for its diverse biological action. PLoS One (2010) 0.85

Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents. J Pharm Pharmacol (2005) 0.84

Aggregation behavior of ibuprofen, cholic acid and dodecylphosphocholine micelles. Biochim Biophys Acta (2012) 0.82

Gastric alkalinization after major trauma. J Trauma (2008) 0.81

Phospholipid actions on PGHS-1 and -2 cyclooxygenase kinetics. Prostaglandins Other Lipid Mediat (2007) 0.81

Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety. Gut Liver (2012) 0.80

In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion (2012) 0.80

Cellular and organismal toxicity of the anti-cancer small molecule, tolfenamic acid: a pre-clinical evaluation. Cell Physiol Biochem (2013) 0.79

Structure and dynamics of cholic acid and dodecylphosphocholine-cholic acid aggregates. Langmuir (2010) 0.78

Role of phospholipids in protection of the GI mucosa. Dig Dis Sci (2013) 0.78

Effect of lactoferrin on Helicobacter felis induced gastritis. Biochem Cell Biol (2002) 0.78

Endotoxin-induced changes in phospholipid dynamics of the stomach. J Surg Res (2012) 0.76